ALKEM · Healthcare
The board meets on 12 Nov 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3,440 cr | ₹3,324 cr | ₹2,936 cr | ₹3,032 cr | ₹3,415 cr | ₹3,374 cr | ₹3,144 cr | ₹3,371 cr | ₹4,001 cr | ₹3,737 cr | ₹3,603 cr | ₹3,740 cr |
| YoY | — | — | — | +2% | −1% | +2% | +7% | +11% | +17% | +11% | +15% | +11% |
| EBITDA margin | 21.7% | 21.3% | 13.7% | 20.1% | 22.0% | 22.5% | 12.4% | 21.9% | 23.0% | 22.2% | 14.3% | 20.5% |
| Other income, % of PBT | 1% | 6% | 21% | 19% | 17% | 13% | 37% | 19% | 12% | 12% | 15% | 20% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 5% | 8% | 17% | 11% | 10% | 12% | 18% | 13% | 13% | 16% | 40% | 32% |
| Net profit | ₹615 cr | ₹604 cr | ₹304 cr | ₹550 cr | ₹702 cr | ₹641 cr | ₹322 cr | ₹668 cr | ₹779 cr | ₹653 cr | ₹251 cr | ₹521 cr |
| YoY | — | — | — | +91% | +14% | +6% | +6% | +21% | +11% | +2% | −22% | −22% |
| Core profit YoY | — | — | — | +74% | +1% | +4% | −14% | +25% | +23% | +8% | +43% | −0% |
| EPS | ₹51.90 | ₹49.76 | ₹24.55 | ₹45.60 | ₹57.60 | ₹52.34 | ₹25.58 | ₹55.56 | ₹63.99 | ₹53.19 | ₹19.78 | ₹43.49 |
| Flags | · | · | · | 1 | ✓ | ✓ | 2 | ✓ | ✓ | ✓ | ✓ | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.